Article

Medical, Surgical, and Mechanical Advances in Adult and Pediatric Heart Failure Treatment

These CME programs explore key concepts in the clinical presentation, diagnosis, and management of heart failure in children and adults.

Beyond Pharmacology in Advanced Heart Failure: The Efficacy of Mechanical Circulatory Support Credits: 1.00

Fee: None

Expiration Date: November 30, 2010

Multimedia: Audio/Visual

Created to “educate cardiologists and associated healthcare professionals on the management of patients with HF and the application of risk management strategies to screen candidates for mechanical circulatory support either as bridge-to-transplant or destination therapy,” this activity covers patient selection for optimal outcomes for mechanical circulatory support, patient selection criteria for the use of implantable ventricular assist devices, patient care and quality of life, and more. The program also discusses late-breaking results from the HeartMate II Destination Therapy clinical trial.

Click here to access this third-party CME program.

Heart Failure in Children

Credits: 1.00

Fee: None

Expiration Date: July 31, 2010

Multimedia: None

The introduction to this CME activity draws a distinction between adult and pediatric heart failure, noting that “In contrast to adults in whom ischemic heart disease is the most common etiology of heart failure, in children, a range of defects, including congenital heart defects, systemic metabolic disorders that affect the myocardium, tachyarrhythmias, and acquired heart disease can cause heart failure to develop.” With this in mind, this activity outlines the etiologies of heart failure in children and reviews recent medical advances that have improved the morbidity and mortality of heart failure in the pediatric population. This activity also provides an overview of the “clinical presentation, diagnosis and management of heart failure in children.”

Click here to access this third-party CME program.

Related Videos
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Steve Nissen, MD | Credit: Cleveland Clinic
Harpreet Bhatia, MD: Benefits of Universal Screening for Lp(a) Levels
© 2024 MJH Life Sciences

All rights reserved.